The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s post-traumatic stress disorder therapeutics market report forecasts the post-traumatic stress disorder therapeutics market size to grow to $4.82 Billion by 2027, with a CAGR (compound annual growth rate) of 9almost 9%.

Learn More On The Post-Traumatic Stress Disorder Therapeutics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/post-traumatic-stress-disorder-therapeutics-global-market-report

Post-Traumatic Stress Disorder Therapeutics Market Size Forecast
The global post-traumatic stress disorder therapeutics market is expected to grow from $3.15 billion in 2022 to $3.42 billion in 2023 at a compound annual growth rate (CAGR) of 8.72%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The post-traumatic stress disorder therapeutics market size is expected to reach $4.82 billion in 2027 at a CAGR of 8.96%.

North America held the largest post-traumatic stress disorder therapeutics market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Post-Traumatic Stress Disorder Therapeutics Market Driver ­– Rise In The Burden Of Post-Traumatic Stress Disorder Cases Across The Globe
For example, the United States body of Veterans Affairs, a US-based government body, estimates that over 8 million Americans would suffer from PTSD by 2021. As a result, the rising prevalence of post-traumatic stress disorder (PTSD) cases is propelling the post-traumatic stress disorder treatments market forward.

Request for A Sample Of The Global Post-Traumatic Stress Disorder Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9214&type=smp

Key Post-Traumatic Stress Disorder Therapeutics Market Trend – Strategic Collaborations, Funding, And Investments
Major industry players are forming strategic alliances and investing in their businesses in order to increase their market position. For example, in January 2022, Professor Dan Lubman AM, Dr. Shalini Arunogiri, and Dr. Paul Liknaitzky of Monash University were awarded more than $1.9 million as part of an interdisciplinary research team to study the effectiveness of MDMA-assisted psychological treatment for treating alcohol use disorder (AUD) and post-traumatic stress disorder (PTSD). The programme is one of seven clinical studies launched this month by the Federal government as part of the Medical Research Future Fund (MRFF) to investigate the use of potentially groundbreaking combination therapies to treat severe mental disorders.

Post-Traumatic Stress Disorder Therapeutics Market Segment
1) By Drug Class: Antidepressants, Anti-Anxiety, Antihypertensive, Monoamine Oxidase (MAOs), Antipsychotics Or Second Generation Antipsychotics (SGOs), Beta-Blockers, Other Classes
2) By Age Group: Pediatric, Geriatric, Adult
3) By End User: Mental Health Center, Hospitals, Outpatient Clinics, Other End Users

Post-Traumatic Stress Disorder Therapeutics Market Major Players and Strategies
Major players in the post-traumatic stress disorder therapeutics market are Novartis AG, Pfizer Inc., Bionomics Ltd., Apotex Inc., GlaxoSmithKline PLC., Otsuka Pharmaceutical Co. Ltd., Eli Lilly and Company, Aurobindo Pharma Limited, Merck KGaA, Sun Pharmaceuticals Pvt Ltd., Strategic Behavioral Health, Jazz Pharmaceuticals, Bionomics, Behavioral Health Network Inc., AstraZeneca PLC., Apotex Inc., Prometheon Pharma LLC., Ligand Pharmaceuticals Incorporated, Lycera Corp. and JSC Valenta Pharm.

Jazz Pharmaceuticals Ireland Limited, an Irish biopharmaceutical company, bought SpringWorks’ fatty acid amide hydrolase (“FAAH”) inhibitor programme, comprising PF-04457845, for an unknown sum in October 2020. Jazz will first focus on developing PF-04457845 in order to investigate its potential for treating post-traumatic stress disorder (“PTSD”) and its symptoms. SpringWorks is a clinical-stage biopharmaceutical business situated in the United States.

The Post-Traumatic Stress Disorder Therapeutics Global Market Report 2023 covers regional data on post-traumatic stress disorder therapeutics market size, post-traumatic stress disorder therapeutics market trends and drivers, opportunities, strategies, and post-traumatic stress disorder therapeutics market competitor analysis. The countries covered in the post-traumatic stress disorder therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Ptsd is an acronym for post-traumatic stress disorder. Therapeutics are medications used to treat post-traumatic stress disorder (PTSD), a mental health disease caused by either experiencing or witnessing a traumatic event. Post-traumatic stress disorder treatment can help people enhance their thinking abilities, adjust their physical activities, and recover control over their lives. Medication, therapy, self-care, and diet are all used to treat post-traumatic stress disorder.

View More Reports Related To The Post-Traumatic Stress Disorder Therapeutics Market –
Post-Harvest Treatment Global Market Report 2023
Plasma Protein Therapeutics Global Market Report 2023
Antisense & RNAi Therapeutics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: